Hematological Effect of Water Extracts of Cham-Dang-Gui on Cyclophosphamide Induced Anemic Rat

Cyclophosphamide로 유도된 빈혈 흰쥐에서 참당귀 열수추출물이 혈액학적 빈혈지표에 미치는 영향

  • 한진아 (경희대학교 동서의학대학원 의학영양학과) ;
  • 장기효 (경희대학교 동서의학대학원 의학영양학과) ;
  • 강순아 (경희대학교 동서의학대학원 의학영양학과) ;
  • 조여원 (임상영양연구소)
  • Published : 2003.12.01

Abstract

Anemia, the condition of the diminished concentration of hemoglobin per erythrocyte is common in patients with cancer and is a frequent complication of myelosuppressive chemotherapy. Cham-Dang-Gui (Angelicae Gigantis Radix) has been used in traditional Korean medicine to treat hematologic deficiencies. In this study, Cyclophosphamide (CYP), an alkylating agent that has a broad spectrum of anti-cancer activities, was intraperitoneally injected into the experimental animals to suppress the bone marrow thereafter, causing anemia. The hemopoietic effects of Cham-Dang-Gui were examined using anemic rat model. Rats were divided into five groups: CON (control group), ANS (CYP-injected + normal diet), AND (CYP-injected + normal diet + Cham-Dang-Gui), ALS (CYP-injected + low iron diet), and ALD (CYP-injected + low iron diet + Cham- Dang-Gui) groups. CYP (30 mg/kg) was intraperitoneally injected to rats for 3 days to induce anemic condition. Saline or Cham-Dang-Gui was administrated orally during the entire experimental period. CYP injection decreased body weight gain and food consumption in comparison with CON group. Oral administration of Cham-Dang-Gui extract with normal iron diet significantly prevented the lower body weight gain. The blood level of hemoglobin, iron status (serum iron, transferrin, ferritin and TIBC) and blood level of vitamin B-12 in Cham-Dang-Gui treated groups were significantly higher than those of Cham-Dang-Gui untreated groups regardless of amount of iron in the diet. Taken together, it could be concluded that the Cham-Dang-Gui extract could improve anemic condition induced by CYP injection by improving hematological value, iron status and vitamin B12 status in rats.

Keywords

References

  1. Hematology for medical technologists Seo,D.G.;Na,J.S.;Lee,G.S.
  2. Semin Hematol v.19 no.1 Manifestations of iron deficiency Dallman,P.R.
  3. Lancet v.348 no.9033 Randomized study of cognitive effects of iron supplementation in non-anemic iron deficient adolescent girls Bruner,A.B.;Joffe,E.;Duggan,A.K.;Casella,J.F.;Brandt,J. https://doi.org/10.1016/S0140-6736(96)02341-0
  4. Hematology Medical collage of Seoul University
  5. Kor J Pharmacol v.31 no.3 Hemopoietic effects of Rhizoma Rehmanniae Preparata on Cyclophosphamide-induced pernicious anemia in rats Ma,J.Y.;Ha,C.S.;Sung,H.J.;Zee,O.P.
  6. Am J Clin Oncol v.25 no.4 Anemia in oncology practice: relation to diseases and their therapies Tas,F.;Eralp,Y.;Basaran,M.;Sakar,B.;Alici,S.;Argon,A.;Bulutlar,G.;Camlica,H.;Aydiner,A.;Topuz,E. https://doi.org/10.1097/00000421-200208000-00011
  7. Phytother Res v.13 no.6 Modulatory effects of ixora coccinea flower on cyclophosphamide-induced toxicity in mice Latha,P.G.;Panikkar,K.R. https://doi.org/10.1002/(SICI)1099-1573(199909)13:6<517::AID-PTR524>3.0.CO;2-Y
  8. Remedy of diet Mo,S.M.;Lee,Y.S.;Gu,J.O.;Son,S.M.
  9. Med Pediatr Oncol v.39 no.4 Interventions for anemia in pediatric cancer patients Ruggiero,A.;Riccardi,R. https://doi.org/10.1002/mpo.10184
  10. Kor J Hematol v.28 Erythropoiethn Ju,G.Z.
  11. Med Pediatr Oncol v.39 no.4 Recombinant human erythropoietin in pediatric oncology: a review Feusner,J.;Hastings,C. https://doi.org/10.1002/mpo.10187
  12. Pharmacotherapy v.22 Overview of cancer-related anemia : focus on the potential role of darbepoetin alfa Valley,A.W. https://doi.org/10.1592/phco.22.14.150S.33400
  13. Kor J Hematol v.27 Remedy of mixed immune in aplastic anemia patient Kim,D.U.;Jin,J.L.;Lee,J.U.;Han,C.H.;Min,S.S.;Kim,H.G.;Park,J.W.;Kim,C.C.;Kim,D.I.
  14. Kor J Hematol v.27 Recombinant human granulocyte colony stimulation factor treatment of apriority agranulocytosis: 2 Case Report Cha,B.H.;Oh,S.H.;Yu,C.J.;Yang,C.Y.;Kim,G.Y.
  15. Clinical applied of herb Lee,S.I.;Ahn,D.G.;Shin,M.G.;No.S.H.;Lee,Y.J.;Kim,K.H.
  16. Int J Immunopharmacol v.11 no.7 Effects of traditional Chinese herbal medicine, Ren-shen-yang-rong-tang on hematopoietic stem cells in mice Miura,S.;Kawamura,I.;Yamada,A.;Kawakita,T.;Kumazawa,Y.;Himeno,K.;Nomoto,K. https://doi.org/10.1016/0192-0561(89)90131-8
  17. Cung/TSA China v.25 12 Cases of aplastic anemia treated mainly by remedy Chinese drugs Liu,X.L.
  18. Exp Hematol v.18 no.1 Effects of Zuzen-taiho-toh (Tj-48), a traditional oriental medicine, on hemopoietic recovery from radiation injury in mice Onishi,Y.;Yasumizu,R.;Fan,H.X.;Liu,J.;Takao-Liu,F.;Komatsu,Y.;Hosoya,E.;Good,R.A.;Ikehara,S.
  19. Am J Kidney Dis v.34 no.2 Hematopoietic effect of Radix angelicae sinensis in a hemodialysis patient Bradley,R.R.;Cunniff,P.J.;Pereira,B.J.;Jaber,B.L. https://doi.org/10.1016/S0272-6386(99)70367-7
  20. Kor J Pharmacol v.38 Immunologic characteristic on extract of Old anter Kim,H.S.;Heu,I.H.;Lee,S.J.;Ahn,H.S.
  21. Haematopoiesis effects of Dang-Gui Oh,H.S.
  22. Pediatr Clin North Am v.43 no.3 Interpretation of the complete blood count Walters,M.C.;Abelson,H.T. https://doi.org/10.1016/S0031-3955(05)70424-7
  23. Kor J Pharmacol v.29 no.4 Homopoietic effects of Deer blood on cyclophosphamide induced pernicious anemia Park,K.J.;Hong,S.B.;Kim,E.H.;Ma,J.Y.;Eun,Y,A.;Kim,H.S.
  24. Kor J Nursing v.30 no.3 The relationship of anorexia, nansea, vomitin and oral intake and identify the influence these side effects on the nutritional status in patients receiving chemotherapy Yhang,Y.H.;Lee,D.S.
  25. Herbolog Han,D.S.
  26. Cancer v.55 no.3 Erythrocyte mean corpuscular volume during cytotoxic therapy and the risk of secondary leukemia De Gramont A;Rioux,E.;Drolet,Y.;Delage,J.M. https://doi.org/10.1002/1097-0142(19850201)55:3<493::AID-CNCR2820550302>3.0.CO;2-5
  27. Sem Hop v.60 no.14 Changes in the mean corpuscular volume during the cytotoxic treatment of cancer and risk of secondary leukemia. Perliminary results De Gramont A;Rioux,E.;Drolet,Y.;Barry,A.;Delage,J.M.
  28. Blood v.80 no.7 Progress in understanding the pathogenesis of the anemia of chronic disease Means,R.T.Jr.;Krantz,S.B.
  29. Semin Hematol v.3 no.4 The anemia of chronic disorders Cartwright,G.E.
  30. Oncology v.16 no.9 Anemia in cancer patients: significance, epidemiology and current therapy Tchekmedyian,N.S.
  31. Hematology(6th ed.) Beutler,E.;Lichtman,M.A.;Coller,B.S.
  32. Medicine v.70 no.4 Neurologic aspects of cobalamine deficiency Healton,E.B.;Savage,D.G.;Brust,J.C.;Garrett,T.J.;Lindenbaum,J.
  33. Am J Med v.96 no.3 Sensitivity of serum methylmalonic acid and total homocysteine determinations for deagnosing cobalamin and folate deficiencies Savage,D.G.;Lindenbaum,J.;Stabler,S.P.;Allen,T.H. https://doi.org/10.1016/0002-9343(94)90149-X
  34. Recommended Dietary Allowance for Korean(7th ed.) Korean Nutrition Society
  35. Pharmacology of Korean Herbs Kim,H.C.
  36. J Cell Physiol v.91 no.3 Conditions controlling the proliferation of haemopoietic stem cells in vitro Dexter,T.M.;Allen,T.D.;Lajtha,L.G.
  37. Blood v.90 no.9 Thrombopoietin is synthesized by bone marrow stromal cells Guerriero,A.;Worford,L.;Holland,H.K.;Guo,G.R.;Sheehan,K.;Waller,E.K.
  38. Blood v.86 no.4 Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand Banu,N.;Wang,J.F.;Deng,B.;Groopman,J.E.;Avraham,H.
  39. Blood v.81 no.10 Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 β(IL-1 β), IL-6, IL-3, interferon-γ, and erythropoietin Brugger,W.;Mocklin,W.;Heimfeld,S.;Berenson,R.J.;Mertelsmann,R.;Kanz,L.
  40. Blood v.58 no.6 Serum erythropoietin (ESF) titers in anemia De Klerk G;Rosengarten,P.C.J.;Vet R.J.W.M.;Goudsmit,R.
  41. Klinische Wochenschrift v.68 Serum erythropoietin level: Relationship to blood haemoglobin concentration and erythrocytic activity of the bone marrow Jelkmann,W.;Widemann,G. https://doi.org/10.1007/BF01648581
  42. European J Haematology v.47 Changes in serum erythropoietin levels during allogeneic bone marrow transplantation Grace,R.J.;Kendall,R.G.;Chapman,C.;Hartley,A.E.;Barnard,D.L.;Norfolk,D.R.
  43. Mol Genet Metab v.67 no.2 Regulation of erythropoietin gene expression depends on two different oxygen-sensing mechanisms Daghman,N.A.;McHale,C.M.;Savage,G.M.;Price,S.;Winter,P.C.;Maxwell,A.P.;Lappin,T.R. https://doi.org/10.1006/mgme.1999.2851
  44. Am J Physiol Endocrinol Metab v.279 no.6 Tissue-specific regulation of erythropoietin production in the marine kidney, brain, and uterus Chikuma,M.;Masuda,S.;Kobayashi,T.;Nagao,M.;Sasaki,R.
  45. Blood 15 v.94 no.6 Regulation of the erythropoietin gene Ebert,B.L.;Bunn,H.F.
  46. Kidney Int v.51 no.2 Erythropoietin gene regulation depends on heme dependent oxygen sensing and assembly of interacting transcription factors Huang,L.E.;Ho,V.;Arany,Z.;Krainc,D.;Galson,D.;Tendler,D.;Li-vingston,D.M.;Bunn,H.F. https://doi.org/10.1038/ki.1997.76
  47. Kor J Immunol v.21 no.2 Effect of korean traditional medicine on murine hernatopoiesis (Ⅰ)-Regulation of hematopoietic cytokine expression Kim,S.H.;Lim,J.S.